Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients

This study investigated the effect of grapefruit juice on cyclosporine A (CsA) bioavailability in 10 renal transplant patients. Under CsA steady state conditions, patients were randomly administered their usual dose of CsA with either 8 ounces of grapefruit juice or 8 ounces of water, Using a crossover design, a 12-hr pharmacokinetic study was then conducted. Grapefruit juice increased the area under the concentration versus time curve (4218+/-1497 ng . hr/ml [grapefruit juice] vs. 3415+/-1288 ng . hr/ml [water], P=0.029) and 12-hr trough (244+/-214 ng/ml [grapefruit juice] vs. 132+/-56 ng/ml [water], P=0.09), but it did not change peak concentration (734+/-290 ng/ml [grapefruit juice] vs. 708+/-305 ng/ml [water], P=0.76). In addition, grapefruit juice delayed the time to peak concentration compared with water (5.4+/-3.0 hr [grapefruit juice] vs. 2.8+/-0.8 hr [water], P=0.025). These data suggest that concurrent administration of grapefruit juice with CsA will delay the absorption of CsA and increase the drug exposure of CsA without changing peak concentration.